The estimated Net Worth of Arani Bose is at least 89.1 百万$ dollars as of 4 March 2024. Arani Bose owns over 7,500 units of Penumbra Inc stock worth over 33,238,319$ and over the last 9 years he sold PEN stock worth over 55,407,480$. In addition, he makes 501,648$ as Chief Innovator、 Director at Penumbra Inc.
Arani has made over 43 trades of the Penumbra Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 7,500 units of PEN stock worth 1,876,500$ on 4 March 2024.
The largest trade he's ever made was exercising 300,000 units of Penumbra Inc stock on 23 September 2015 worth over 171,000$. On average, Arani trades about 25,568 units every 66 days since 2015. As of 4 March 2024 he still owns at least 164,294 units of Penumbra Inc stock.
You can see the complete history of Arani Bose stock trades at the bottom of the page.
Dr. Arani Bose M.D. serves as Chief Innovator, Director of the Company. Dr. Bose was Chairman of the Board and Chief Medical Officer from 2005 until 2015 and currently serves as Chief Innovator. Prior to founding Penumbra, Dr. Bose was an Assistant Professor of Radiology and Neurology at New York University (NYU) School of Medicine from 1997 to 2004, where he also had a clinical practice. While at NYU, Dr. Bose co-founded SMART Therapeutics. Dr. Bose received a B.A. from Stanford University and an M.D. from the University of Colorado School of Medicine with residency and fellowships at Yale University School of Medicine and NYU Medical Center.
As the Chief Innovator、 Director of Penumbra Inc, the total compensation of Arani Bose at Penumbra Inc is 501,648$. There are 6 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of 2,556,370$.
Arani Bose is 58, he's been the Chief Innovator、 Director of Penumbra Inc since 2015. There are 4 older and 11 younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
Arani's mailing address filed with the SEC is ONE PENUMBRA PLACE, , ALAMEDA, CA, 94502.
Over the last 9 years, insiders at Penumbra Inc have traded over 197,637,326$ worth of Penumbra Inc stock and bought 700 units worth 109,480$ . The most active insiders traders include Adam Elsesser、Arani Bose、James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of 2,030,383$. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth 159,614$.
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
Penumbra Inc executives and other stock owners filed with the SEC include: